News for the Multiple Sclerosis Community

UK MS Society LDN Response

Slightly less negative than the NMSS, the UK MS Society weighs in on with their thoughts on Low Dose Naltrexone. While they present reasonable caution, they indicate that a clinical trial should be done to find out and suggest that they would be receptive to getting a proposal and would even help draft it. Isn't that how an MS Society is supposed to be?